Xiaofei Chang
YOU?
Author Swipe
View article: Segments-aware universal adversarial perturbations purification on 3D point cloud classifiers
Segments-aware universal adversarial perturbations purification on 3D point cloud classifiers Open
Introduction 3D point cloud classifiers, while powerful for representing real-world objects and environments, are vulnerable to adversarial perturbations, particularly Universal Adversarial Perturbations (UAPs). These UAPs pose significant…
View article: Consensus-Based Formation Control for Heterogeneous Multi-Agent Systems in Complex Environments
Consensus-Based Formation Control for Heterogeneous Multi-Agent Systems in Complex Environments Open
The purpose of this paper is to develop formation control strategies for heterogeneous multi-intelligent-agent systems in complex environments, with the goal of enhancing their performance, reliability, and stability. Complex flight condit…
View article: Distributed photovoltaic supportability consumption method considering energy storage configuration mode and random events
Distributed photovoltaic supportability consumption method considering energy storage configuration mode and random events Open
In order to improve the control capability of distributed photovoltaic support, a distributed photovoltaic support consumption method based on energy storage configuration mode and random events is proposed. A networked and constrained par…
View article: Multi-consensus formation control by artificial potential field based on velocity threshold
Multi-consensus formation control by artificial potential field based on velocity threshold Open
This study proposes a multi-consensus formation control algorithm by artificial potential field (APF) method based on velocity threshold. The algorithm improves the multi-consensus technique. This algorithm can split a group of agents into…
View article: 40P Small molecule inhibitor HI-TOPK-032 improves NK-92MI cells infiltration into ovarian tumors
40P Small molecule inhibitor HI-TOPK-032 improves NK-92MI cells infiltration into ovarian tumors Open
The efficiency of adoptively transferred natural killer (NK) cells for treating solid tumors is hindered by their difficulty in entering tumors from the bloodstream and their inability to prolong viability in the absence of IL-2. Among dif…
View article: Supplementary Figure 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Figure 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Figure 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Supplementary Table 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Table 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Table 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Data from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Data from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Human papillomavirus (HPV) type 16 can integrate into the host genome, thereby rendering the viral coding genes susceptible to epigenetic modification. Using bisulfite genomic sequencing, we determined the methylation status of all 110 CpG…
View article: Supplementary Figure 1 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy
Supplementary Figure 1 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy Open
PDF file - 191K, Tumor HPV status and serum TGF-beta1 levels of HNSCC patients
View article: Supplementary Figure 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Figure 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Figure 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Supplementary Table 3 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Table 3 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Table 3 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Supplementary Table 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Table 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Table 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Supplementary Table 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Table 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Table 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Data from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy
Data from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy Open
EGF receptor (EGFR)–targeted monoclonal antibodies (mAb), such as cetuximab, execute their antitumor effect in vivo via blockade of receptor–ligand interactions and engagement of Fcγ receptors on immune effector cells that trigger antibody…
View article: Supplementary Figure 1 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy
Supplementary Figure 1 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy Open
PDF file - 191K, Tumor HPV status and serum TGF-beta1 levels of HNSCC patients
View article: Supplementary Table 2 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy
Supplementary Table 2 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy Open
PDF file - 70K, A, Serum levels of the indicated cytokines in patients with HNSCC and pleomorphic adenoma (non-cancer control). B, Comparison of serum TGF-beta1 levels in non-cancer controls and patients with HNSCC at the time of new diagn…
View article: Supplementary Table 2 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy
Supplementary Table 2 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy Open
PDF file - 70K, A, Serum levels of the indicated cytokines in patients with HNSCC and pleomorphic adenoma (non-cancer control). B, Comparison of serum TGF-beta1 levels in non-cancer controls and patients with HNSCC at the time of new diagn…
View article: Data from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Data from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Human papillomavirus (HPV) type 16 can integrate into the host genome, thereby rendering the viral coding genes susceptible to epigenetic modification. Using bisulfite genomic sequencing, we determined the methylation status of all 110 CpG…
View article: Supplementary Table 1 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy
Supplementary Table 1 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy Open
PDF file - 256K, Clinical characteristics of patients with HNSCC
View article: Supplementary Figure 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Figure 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Figure 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Data from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy
Data from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy Open
EGF receptor (EGFR)–targeted monoclonal antibodies (mAb), such as cetuximab, execute their antitumor effect in vivo via blockade of receptor–ligand interactions and engagement of Fcγ receptors on immune effector cells that trigger antibody…
View article: Supplementary Table 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Table 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Table 1 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Supplementary Figure 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Figure 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Figure 2 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Supplementary Table 3 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
Supplementary Table 3 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers Open
Supplementary Table 3 from Characterization of the Methylation Patterns in Human Papillomavirus Type 16 Viral DNA in Head and Neck Cancers
View article: Supplementary Table 1 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy
Supplementary Table 1 from Inhibition of TGF-β Enhances the <i>In Vivo</i> Antitumor Efficacy of EGF Receptor–Targeted Therapy Open
PDF file - 256K, Clinical characteristics of patients with HNSCC
View article: Supplementary Figures S1-S2 from A Promoter Methylation Pattern in the <i>N</i>-Methyl-d-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma
Supplementary Figures S1-S2 from A Promoter Methylation Pattern in the <i>N</i>-Methyl-d-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma Open
Supplementary Figures S1-S2 from A Promoter Methylation Pattern in the N-Methyl-d-Aspartate Receptor 2B Gene Predicts Poor Prognosis in Esophageal Squamous Cell Carcinoma